WO2010115249A1 - Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy - Google Patents
Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy Download PDFInfo
- Publication number
- WO2010115249A1 WO2010115249A1 PCT/BR2009/000102 BR2009000102W WO2010115249A1 WO 2010115249 A1 WO2010115249 A1 WO 2010115249A1 BR 2009000102 W BR2009000102 W BR 2009000102W WO 2010115249 A1 WO2010115249 A1 WO 2010115249A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lactating animals
- subclinical mastitis
- treatment method
- dynamic therapy
- photosensitive agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0644—Handheld applicators
Definitions
- the present application of Invention Privilege belongs to the therapeutic procedures field having the objective of defining an innovative subclinical mastitis treatment method in lactating animals using "Photo Dynamic Therapy” (PDT), that consists on applying a photosensitive agent together laser irradiation on the infected mammary quarter, using an already existing low- energy laser emission equipment (LEDs), that can be adapted to any acrylic instrument tip, allowing its introduction from the animal teat orifice till the desired location, so the radiation reaches the entire glandular part of the infected teat in three different levels in only one application with an established nism to death without loss or excessive exposure.
- PDT Photo Dynamic Therapy
- LEDs low- energy laser emission equipment
- bovine mastitis is currently one of the most serious problems found on dairy husbandry, with high prevalence in flocks all around the world that is being studied since the eighteenth century and even today with a lot of studies about this pathology, it still is the disease with highest economical impact over milk production.
- Subclinical mastitis causes a silent reduction of the milk capacity secretion of the affected mammary quarter and it can cause a huge impact, since the use of veterinary antimicrobial (antibiotics) chemical substances increases.
- the conventional treatment is done with intra mammary antibiotics application and, in last cases, when all the animal organism is affected, the application is parenteral (intramuscular).
- the subclinical mastitis treatment with antibiotics in addition to present its residues on milk, can also produce residues on other animal origin products intended to human consumption and thus indirectly causing bacteria resistance on humans.
- the Photo Dynamic Therapy is the use of a low-energy laser producing a photochemical effect when applied against living tissue and in bacteria's case is maximized with the pigment use (photosensitive agent) plus the laser irradiation.
- the laser therapy was used in women on acute mastitis treatment applying a high power laser. Because animal's skin is very thick, a factor that decreases laser radiation absorption, the great innovation of Photo Dynamic Therapy to treat mastitis in lactating animals is the topic within the animal's mammary gland, as a more efficient method that maximizes the bacteria death in association the photosensitive agent administration.
- LEDs low-energy laser
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Subclinical mastitis treatment method in lactating animals using photo dynamic therapy is an innovative therapeutic method to mastitis treatment in lactating animals that consists in an optical treatment within the animal's mammary gland, maximizing with more efficiency the bacteria death with the administration of photosensitive agent. Thus, it was used low-energy laser (LEDs) emission equipments with no thermal effect, already existents, substituting the usual tips by acrylic ones with specific dimensions that enable its penetration on the animal teat orifice to guide the light emission to reach the gland internally irradiating in three distinct deep levels with the energy density properly adjusted to each of them in only one application direct on the infection focus together the introduction of a photosensitive agent into the teat by a urethral probe, that stimulated by low-energy laser (LEDs) irradiation, has absorbed the radiation an has transmitted these captured energy to the cells, triggering the desired photosensitization effect, ie the death of microorganisms by light in presence of a photosensitive agent.
Description
METHOD FOR TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING ANIMALS USING PHOTODYNAMIC THERAPY
Field of Invention
The present application of Invention Privilege belongs to the therapeutic procedures field having the objective of defining an innovative subclinical mastitis treatment method in lactating animals using "Photo Dynamic Therapy" (PDT), that consists on applying a photosensitive agent together laser irradiation on the infected mammary quarter, using an already existing low- energy laser emission equipment (LEDs), that can be adapted to any acrylic instrument tip, allowing its introduction from the animal teat orifice till the desired location, so the radiation reaches the entire glandular part of the infected teat in three different levels in only one application with an established nism to death without loss or excessive exposure.
The use of this innovative subclinical mastitis treatment method in lactating animals through Photo Dynamic Therapy (PDT) makes short, with total elimination of the microorganism, these infections duration, a fundamental importance aspect in control and prevention programs of mastitis during lactation; eliminates the effective milk secretion reduction, as the milked milk disposal, both originated by the infection by microorganism presence and by the antibiotics residues applied on usual treatments. History of Invention
Studies show that bovine mastitis is currently one of the most serious problems found on dairy husbandry, with high prevalence in flocks all around the world that is being studied since the eighteenth century and even today with a lot of studies
about this pathology, it still is the disease with highest economical impact over milk production.
Subclinical mastitis causes a silent reduction of the milk capacity secretion of the affected mammary quarter and it can cause a huge impact, since the use of veterinary antimicrobial (antibiotics) chemical substances increases.
The conventional treatment is done with intra mammary antibiotics application and, in last cases, when all the animal organism is affected, the application is parenteral (intramuscular).
The concern with a growing antibiotics residues presence on milk generates a search for alternative methods to the classical approach of this substances, for example the use of homeopathic and biotherapy medicines prepared from bacteria, fungi, viruses, pathological secretions or excretions, mites, worms, etc. either animal or vegetal.
State of Technical Disabled Points
1 - The conventional long duration treatment to microorganism eradication with antibiotics application, either via mammary or injectable, compromises the milk quality by the antimicrobial chemical substance (antibiotics) presence, coming from the treatment, making necessary to discard the milk for up to 10 days.
2 - The subclinical mastitis treatment with antibiotics, in addition to present its residues on milk, can also produce residues on other animal origin products intended to human consumption and thus indirectly causing bacteria resistance on humans.
3 - The homeopathic medicines use,
although the results are positive, the treatment has a long duration compromising the milk production.
4 - The biotherapy medicines application was effective on mastitis preventive treatment, but with a long duration on the infection treatment, also compromising the milk production.
Invention summary
Thinking about these problems that, after much research and studies, the inventors have created and developed an innovative subclinical mastitis treatment method, that eliminates the effective milk production reduction and disposal, meeting the increasingly stringent requirement of national and international institutions about the antimicrobial residues absence, through Photo Dynamic Therapy already known and used in humans on skin, intestine and other cancer treatments with low energy density and by dentists to eliminate any bacteria that may stay after a treatment before covering the tooth with high energy density, however never used on mastitis treatment.
The Photo Dynamic Therapy is the use of a low-energy laser producing a photochemical effect when applied against living tissue and in bacteria's case is maximized with the pigment use (photosensitive agent) plus the laser irradiation. The laser therapy was used in women on acute mastitis treatment applying a high power laser. Because animal's skin is very thick, a factor that decreases laser radiation absorption, the great innovation of Photo Dynamic Therapy to treat mastitis in lactating animals is the topic within the animal's mammary gland, as a more efficient method
that maximizes the bacteria death in association the photosensitive agent administration.
Thus, it was used low-energy laser (LEDs) emission equipments with no thermal effect, already existents, substituting the usual tips by acrylic ones with 100 mm in length and 5 mm in diameter, that enables the penetration on the animal teat orifice to guide the light emission to reach the gland internally. Laser was irradiated in three distinct deep levels with the energy density properly adjusted in 200 J/ cm2 in each one, never tested in animals before, it enabled only one direct application on infection focus. It was also used an introduction of 1 ml of photosensitive agent, Toluidine blue, in teat by urethral probe with a 2,5% concentration, that stimulated by laser irradiation, transmits the captured energy to the cells, triggering the desired photo photosensitization effect, ie the death of microorganisms by light in the presence of a photosensitive agent.
Claims
1 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC THERAPY", characterized by an innovative subclinical mastitis treatment method in lactating animals with the usual Photo Dynamic Therapy (PDT) equipment acrylic tip adequacy, with the energy density (DE) properly adjusted, that enables the topic laser irradiation within the animal mammary gland in only one application in three deep levels and, also, the introduction of photosensitive agent toluidine blue in specific dosage, that when receiving the irradiation causes bactericidal effect, reducing this way the total bacterial count, eliminating the milk disposal by the microorganisms presence;
2 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC
THERAPY", according to the claim 1 , characterized by already existents PDT equipments adequacy with an acrylic tip with 100 mm length and 5 mm in diameter approximated dimensions, that enables in an efficient way its introduction on the animal teat orifice guiding the light emission (irradiation) through the infected mammary quarter till reach the desired treatment location;
3 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC THERAPY", according to claim 1 , characterized by the utilization of a photosensitive agent tuluidine blue with 2,5% concentration, with a bactericidal effect through light irradiation, injected by urethral probe introduced by the teat sphincter till it arrives on the gland cistern;
4 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC
THERAPY", according to claim 1, characterized by having a energy density (DE) properly adjusted and applied in three deep levels in only one application of 200 J/cm2 in each level, being the level 1 near the glandular parenchyma, level 2 on the gland cistern and level 3 on teats base, irradiating for 262 seconds in each level;
5 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC THERAPY", according to the claim 1 , characterized by reduce the total bacterial count and eliminate milk disposal by the microorganisms presence and antibiotics residues applied during usual treatment.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BR2009/000102 WO2010115249A1 (en) | 2009-04-09 | 2009-04-09 | Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BR2009/000102 WO2010115249A1 (en) | 2009-04-09 | 2009-04-09 | Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010115249A1 true WO2010115249A1 (en) | 2010-10-14 |
Family
ID=42935589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2009/000102 WO2010115249A1 (en) | 2009-04-09 | 2009-04-09 | Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010115249A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021151167A1 (en) * | 2020-01-31 | 2021-08-05 | Cosmoaesthetics Pty Ltd | Wearable apparatus for the treatment of mastitis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0596018A (en) * | 1991-10-09 | 1993-04-20 | Matsushita Electric Ind Co Ltd | Probe for laser treating device |
US20060047329A1 (en) * | 2003-10-15 | 2006-03-02 | Yosef Krespi | Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract |
WO2006037599A1 (en) * | 2004-10-03 | 2006-04-13 | Stefan Bernhard | Device for the prevention and treatment of mastitis with light |
WO2007025244A2 (en) * | 2005-08-25 | 2007-03-01 | Houle Philip R | Treatment systems for delivery of sensitizer solutions |
-
2009
- 2009-04-09 WO PCT/BR2009/000102 patent/WO2010115249A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0596018A (en) * | 1991-10-09 | 1993-04-20 | Matsushita Electric Ind Co Ltd | Probe for laser treating device |
US20060047329A1 (en) * | 2003-10-15 | 2006-03-02 | Yosef Krespi | Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract |
WO2006037599A1 (en) * | 2004-10-03 | 2006-04-13 | Stefan Bernhard | Device for the prevention and treatment of mastitis with light |
WO2007025244A2 (en) * | 2005-08-25 | 2007-03-01 | Houle Philip R | Treatment systems for delivery of sensitizer solutions |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021151167A1 (en) * | 2020-01-31 | 2021-08-05 | Cosmoaesthetics Pty Ltd | Wearable apparatus for the treatment of mastitis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wardlaw et al. | Photodynamic therapy against common bacteria causing wound and skin infections | |
JP2007509034A (en) | Antibacterial photodynamic therapeutic compounds based on erythrosin and methods of use thereof | |
CN101060816A (en) | Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis | |
CN205268849U (en) | Antibiotic photosensitive therapeutic instrument | |
JP2009013162A (en) | Photosenstive acne therapeutic agent, photosenstive acne therapeutic agent composition, kit for photodynamic acne therapy, photosensitive sebum secretion inhibitor, photosensitive sebum secretion inhibitor composition and kit for photodynamic sebum secretion inhibitor | |
Šmucler et al. | Comparative study of aminolevulic acid photodynamic therapy plus pulsed dye laser versus pulsed dye laser alone in treatment of viral warts | |
Moreira et al. | Use of photodynamic therapy in the treatment of bovine subclinical mastitis | |
JP2007503917A (en) | Antibacterial photodynamic therapeutic compounds and methods of use thereof | |
WO2010115249A1 (en) | Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy | |
RU2379073C2 (en) | Method of laser treatment of chronic tonsillitis with using photosensitiser | |
JP2018501829A (en) | Medical and veterinary light irradiation for therapeutic compounds | |
KR20130011162A (en) | The method for treating tumor or skin diseases using photodynamic therapy | |
KR101318659B1 (en) | Alopecia seborrheica therapeutics which comprise tryptophan, and kits for photodynamic therapy containing the same | |
CN106614153A (en) | Method for treating goldfish saprolegniasis | |
KR101308507B1 (en) | Acne therapeutics and sebum secernent inhibitor which comprise tryptophan, and kits for photodynamic therapy containing the same | |
Robatto et al. | Blue Ligth Emitting Diode in Treatment of Recurring Vulvovaginal Candidiasis: a Case Report | |
CN114728156B (en) | Medical instrument and medical device | |
US20160354407A1 (en) | Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light | |
RU2398607C1 (en) | Therapy of background, precancerous, malignant and metastatic diseases | |
RU2609735C1 (en) | Method of optimisation of photodynamic therapy of purulent wounds (versions) | |
KR101592145B1 (en) | Apparatus for treating seborrhoeic dermatitis and sterilizing method for infection seborrhoeic dermatitis | |
RU2345796C2 (en) | Method of mastopathy treatment and prevention in animals | |
RU2342962C1 (en) | Method of ramex complex treatment | |
RU2784347C1 (en) | Hydropressive laser photochemical debridement method | |
Al Timimi | Cancer treatment based on the selective accumulation of a photosensitiser and laser light irradiation: A review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09842851 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 21/12/2011) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09842851 Country of ref document: EP Kind code of ref document: A1 |